BSE Live
Jan 01, 16:01Prev. Close
376.25
Open Price
379.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 01, 15:58Prev. Close
376.30
Open Price
379.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
377.65 (727)
| Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 6.68 | 6.68 | 6.68 | 6.58 | 5.72 | |
| Total Share Capital | 6.68 | 6.68 | 6.68 | 6.58 | 96.15 | |
| Reserves and Surplus | 691.50 | 598.87 | 690.53 | 532.51 | 154.60 | |
| Total Reserves and Surplus | 691.50 | 598.87 | 690.53 | 532.51 | 154.60 | |
| Total Shareholders Funds | 698.18 | 605.55 | 697.20 | 539.09 | 250.76 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 494.04 | 548.11 | 372.57 | 213.36 | 484.63 | |
| Deferred Tax Liabilities [Net] | 84.69 | 81.76 | 63.72 | 46.60 | 29.61 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 578.73 | 629.87 | 436.29 | 259.96 | 514.25 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 211.40 | 152.18 | 25.68 | 0.06 | 102.02 | |
| Trade Payables | 132.80 | 147.47 | 96.92 | 122.96 | 96.79 | |
| Other Current Liabilities | 5.42 | 5.34 | 14.93 | 16.79 | 5.55 | |
| Short Term Provisions | 70.37 | 185.75 | 17.53 | 102.51 | 50.75 | |
| Total Current Liabilities | 419.99 | 490.74 | 155.05 | 242.31 | 255.10 | |
| Total Capital And Liabilities | 1,696.90 | 1,726.17 | 1,288.54 | 1,041.37 | 1,020.11 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 508.63 | 502.77 | 299.72 | 263.28 | 126.25 | |
| Intangible Assets | 23.48 | 21.34 | 18.48 | 14.04 | 10.75 | |
| Capital Work-In-Progress | 162.55 | 169.76 | 216.16 | 123.72 | 96.70 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 694.66 | 693.87 | 534.37 | 401.05 | 233.71 | |
| Non-Current Investments | 225.83 | 216.57 | 204.93 | 22.95 | 6.14 | |
| Deferred Tax Assets [Net] | 13.80 | 48.38 | 4.22 | 8.21 | 4.93 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.20 | 0.37 | 0.53 | 0.70 | 0.96 | |
| Total Non-Current Assets | 934.49 | 959.19 | 744.05 | 432.91 | 245.75 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 455.51 | 447.80 | 211.64 | 208.16 | 180.45 | |
| Trade Receivables | 109.41 | 123.88 | 148.26 | 92.92 | 77.45 | |
| Cash And Cash Equivalents | 36.34 | 59.48 | 141.18 | 157.12 | 441.46 | |
| Short Term Loans And Advances | 161.16 | 135.82 | 43.41 | 150.26 | 75.00 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 762.41 | 766.98 | 544.49 | 608.46 | 774.36 | |
| Total Assets | 1,696.90 | 1,726.17 | 1,288.54 | 1,041.37 | 1,020.11 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 31.60 | 48.55 | 41.51 | 14.20 | 92.42 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 313.72 | 457.13 | 274.30 | 348.11 | 209.59 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 40.66 | 45.73 | 19.31 | 52.59 | 19.89 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 34.88 | 44.11 | 23.01 | 16.87 | 25.04 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | 0.10 | 0.10 | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 646.54 | 558.90 | 641.41 | 158.77 | 41.86 | |
| Other Earnings | 4.59 | 4.75 | 0.65 | 16.30 | 4.20 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 225.83 | 216.57 | 204.93 | 22.95 | 6.14 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y